What do you wish you’d invented?
I wish I had invented the treatments to Parkinson’s disease.
What trend do you see shaping the industry?
Over the last 20 years, the use of big data and new technologies have boomed across industries, allowing access to new information and facilitating connection with internal stakeholders and external customers, including Patients, Healthcare Practitioners, Payers and Regulators.
Still, the Pharma industry is yet to fully embrace this change.
This is partially due to the complexity of the current data management landscape, the use of multiple legacy systems, strict regulatory requirements, and embedded old ways of working. Companies need to develop and implement a clear strategy for restructuring their information architecture for better integration of information, access and the use of data, while reducing manual processes as much as possible.
What has made you proud in your career?
I’ve had the privilege to work with visionary leaders in the Life Sciences industry, helping them bring ground-breaking treatments to patients faster.
There is nothing more rewarding than successfully partnering with my clients to go through a change that benefits their organisation for the short and long-term, and ultimately makes a difference in what they do.
Where were you before?
I previously worked as a General engineer, specialising in Chemistry-led projects, optimising chemical processes for the production of a food additive. I also developed and implemented analysis techniques for the central laboratory of a food industry.
Prior to that, I was a Doctor of Philosophy and Chemistry, conducting research on signalling molecules triggering the production of active secondary metabolites within soil-dwelling bacteria.
Why did you choose to work in the life sciences industry?
I chose to work in this industry so that I could continue to contribute towards improving peoples’ quality of life.